275 related articles for article (PubMed ID: 22374305)
1. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M
Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
[TBL] [Abstract][Full Text] [Related]
4. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF.
Amaral SL; Linderman JR; Morse MM; Greene AS
Microcirculation; 2001 Feb; 8(1):57-67. PubMed ID: 11296854
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G
Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of in vivo angiogenesis by angiotensin II receptors.
Walther T; Menrad A; Orzechowski HD; Siemeister G; Paul M; Schirner M
FASEB J; 2003 Nov; 17(14):2061-7. PubMed ID: 14597675
[TBL] [Abstract][Full Text] [Related]
8. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M
J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
11. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity.
Ohashi H; Takagi H; Oh H; Suzuma K; Suzuma I; Miyamoto N; Uemura A; Watanabe D; Murakami T; Sugaya T; Fukamizu A; Honda Y
Circ Res; 2004 Apr; 94(6):785-93. PubMed ID: 14963002
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
Kou B; Vatish M; Singer DR
Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells.
Fleegal-DeMotta MA; Doghu S; Banks WA
J Cereb Blood Flow Metab; 2009 Mar; 29(3):640-7. PubMed ID: 19127280
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes.
Otani A; Takagi H; Oh H; Suzuma K; Matsumura M; Ikeda E; Honda Y
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1192-9. PubMed ID: 10752960
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system.
Watanabe Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Hattori A; Tsujimoto M; Mizutani S
Clin Cancer Res; 2003 Dec; 9(17):6497-503. PubMed ID: 14695154
[TBL] [Abstract][Full Text] [Related]
19. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation.
Yamagishi S; Amano S; Inagaki Y; Okamoto T; Inoue H; Takeuchi M; Choei H; Sasaki N; Kikuchi S
Drugs Exp Clin Res; 2003; 29(2):75-80. PubMed ID: 12951837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
